Brii Biosciences Limited
Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous system diseases. The company develops BRII-778 and BRII-732, which are in phase I clinical trials for the treatment of HIV patients; BRII…
Biotechnology
CN, Beijing [HQ]
Cash Flow Statement
Configuration
In Million USD. Margins, Growth Rates In %
Cash Flow Statement
Sorry, seems like something went wrong
Info
No Data For 2137.HK's Cash Flow Statement
A data error can have several reasons, including but not limited to: Missing data (Most likely), Bugs, Javascript blocking